GTx (Fareston)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
US commercial rights of Fareston. It consist of rights to market, distribute and sell Fareston in the United States. Fareston is a pharmaceutical drug for the treatment of metastatic breast cancer in postmenopausal women.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 175 Toyota Plaza
- 7th Floor
- Memphis, TN 38103
- United States
GTx (Fareston) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore GTx (Fareston)‘s full profile, request access.
Request full access to PitchBookGTx (Fareston) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore GTx (Fareston)‘s full profile, request access.
Request full access to PitchBook